Pallas Capital Advisors LLC Purchases 453 Shares of Eli Lilly and Company (NYSE:LLY)
Pallas Capital Advisors LLC increased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 2.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,441 shares of the company’s stock after acquiring an additional 453 shares during the period. Pallas Capital […]
More Stories
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Short Interest Down 8.5% in November
Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) saw a significant decline in short interest in November. As of November...
Okta (NASDAQ:OKTA) Shares Gap Up on Analyst Upgrade
Okta, Inc. (NASDAQ:OKTA – Get Free Report) gapped up prior to trading on Wednesday after Scotiabank raised their price target...
Danaos Co. (NYSE:DAC) Short Interest Up 8.1% in November
Danaos Co. (NYSE:DAC – Get Free Report) saw a large increase in short interest during the month of November. As...
Bowhead Specialty (NYSE:BOW) Hits New 52-Week High on Analyst Upgrade
Bowhead Specialty Holdings Inc. (NYSE:BOW – Get Free Report) shares reached a new 52-week high on Wednesday after Keefe, Bruyette...
inSure DeFi Price Up 27.5% Over Last 7 Days (SURE)
inSure DeFi (SURE) traded up 12.4% against the US dollar during the twenty-four hour period ending at 12:00 PM E.T....
CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Significant Increase in Short Interest
CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW – Get Free Report) saw a significant increase in short interest in the month of...